semaglutide for heart disease Novo's obesity drug cuts risk of in study Semaglutide in Patients With Obesity

Total professionals and great results

Plant-based and vegetarian diets: an overview and definition of these dietary patterns

H.TsengJ

However, in the context of the use of GLP1RAs in patients with type 2 diabetes, recommendations include patient counselling, starting with the recommended dose titration (considering history of GI events with the previous GLP1RA), management of GI side effects and reevaluation of response

Two vials out of thousands sold

Resveratrol is a natural compound located in the stems, leaves, roots, fruits, and seeds of a variety of plants Its found in its highest concentrations in the skin of red grapes, but can also be found in peanuts, blueberries, and the root of Japanese knotweed The History In the 1990s, resveratrol first popped up on the radar when nutrition scientists suggested it was responsible for the cardiovascular benefits thought to be associated with drinking red wine Resveratrol Improves Cardiovascular and Metabolic Health In people with type 2 diabetes, 1 gram/day of supplemental resveratrol has been found to reduce blood pressure, fasting blood glucose, and fasting insulin levels while increasing HDL levels (Study 1, Study 2, Study 3, Study 4) In obese individuals, 150 mg/day of resveratrol supplementation promoted caloric restriction-like effect s (Study) Participants also had significant decreases in blood pressure, blood glucose, and triglyceride levels When people with non-alcoholic fatty liver disease took a resveratrol supplement of either 300 or 500 mg/day for 3 months, their serum LDL levels, liver fat concentrations, and inflammatory biomarkers all decreased, while their insulin sensitivity increased (Study 1, Study 2) In a study involving 75 people taking a statin, those who also took a 350 mg resveratrol-enriched grape extract daily for 6 months saw a decrease in several cardiovascular risk markers (LDL decreased by 4.5%, oxidized LDL decreased by 20%, and ApoB decreased by 9.8%) (Study) After the 6-month treatment period, participants received double the original dose for another 6 months